Woodline Partners’s Neuphoria Therapeutics NEUP Stock Holding History

Woodline Partners’s Portfolio NEUP Stock Details NEUP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4,537	Closed	-$120K	–	768
2023 Q2	$120K	Sell	4,537 -62	-1%	-$1.72K	﹤0.01%	605
2023 Q1	$143K	Sell	4,599 -7,065	-61%	-$298K	﹤0.01%	603
2022 Q4	$651K	Sell	11,664 -87	-0.7%	-$7.55K	0.01%	582
2022 Q3	$884K	Hold	11,751	–	–	0.01%	546
2022 Q2	$986K	Sell	11,751 -1,661	-12%	-$162K	0.02%	511
2022 Q1	$1.37M	Sell	13,412 -83	-0.6%	-$10.9K	0.02%	446
2021 Q4	$2.03M	Buy	+13,495	New	+$2.07M	0.03%	413

Other funds holding NEUP

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return

FNY Investment Advisers New York $277M AUM 98.95% 1-Year Est. Return

RhumbLine Advisers

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Aspire Private Capital Cornelius, North Carolina $443M AUM 14.48% 1-Year Est. Return